On the edge of our seats for the ZEUS and HERMES trial outcomes on #ziltivekimab in CV and HF patients! ⏳ The anti-inflammatory potential is promising—now, hoping for clinical impact. #ESCCongress European Society of Cardiology Dr. Soumaya Ben-Aicha, PhD Simon Kraler Carol Ann Remme Oren Caspi 🎗️ ESC WG on Atherosclerosis & Vascular Biology Chair

Honoured to have presented our research at #ESC2025, one of the largest cardiology conferences in the world 🫀✨ Over 3 years of collaboration, we achieved 5 accepted abstracts, a true team effort! #Cardiology #Research

Elevated plasma S100A12—a pro-inflammatory protein from neutrophils—is linked to higher risk of major adverse cardiovascular events (MACE) in the UK Biobank cohort, with neutrophils playing a key mediating role. Learn more: ow.ly/2vUr50WQ5QN

Semaglutide promotes bone marrow-derived progenitor cell flux toward an anti-inflammatory and pro-regenerative profile in high-risk patients: the SEMA-VR CardioLink-15 trial In people living with either type 2 diabetes or obesity plus ASCVD risk, semaglutide increased

Interferons in health and diseas cell.com/cell/fulltext/…

In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality vs sitagliptin, but tirzepatide offered no additional benefit over semaglutide. ja.ma/47OIhW3

Advancements in Lipid-Lowering Therapies: Targeting Key Mechanisms in Lipid and Lipoprotein Metabolism! Read the news in #EHJ! academic.oup.com/eurheartj/adva… #lipoproteins #EHJ #cardiotwitter @ESC_journals European Society of Cardiology

SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence SGLT-2 inhibitors have evolved as metabolic drugs due to their multi-system effects and are indicated for the management of HF across the ejection fraction spectrum, type 2 diabetes, and chronic kidney disease

Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease Among a large cohort of patients with T2DM, prescription of SGLT2i and GLP1-RA was low in those with CKD. We observed a “risk-treatment

Inflammation in coronary atherosclerosis Heart_BMJ heart.bmj.com/content/111/17…

Feeling blessed to have such a wonderful team and colleagues 🥰🥰. Thank you Caglar Gök Paul E. Squires and Joanna Ward for a wonderful early birthday celebration & fabulous gifts 🎁 🥂 ##womeninSTEM ##WomeninScience #academia #birthdaycelebrations #UniversityofLincoln

Early birthday celebrations for the legendary Claire E. Hills 🥰 nobody more deserving of a fizz and cake filled afternoon 🥰 #womeninstem #womeninscience #academicchatter #phdlife #phdchat

Celebrating a large win for the team today 🥳🥳🥳. Many thanks to Joanna Ward University of Lincoln CardioRenal Group for making the celebrations this evening that little bit sweeter 🥂🍾. #womeninSTEM #Diabetesresearch #cardiovascular #cardiovasculardisease #type2diabetes #grantsuccess #kidneydisease

Huge congratulations to the legends that are Claire E. Hills Paul E. Squires 🤩🤩 there is nobody more deserving of such a fantastic win 🤩 a fabulous day for team University of Lincoln CardioRenal Group ❤️❤️ #womeninstem #womeninscience #phdlife #phdchat #grantsuccess

🚨 Observational study #T2D + ASCVD · 57% received neither SGLT2i nor GLP-1RA · Mortality ↓ with: • SGLT2i only (HR 0.28) • GLP-1RA only (HR 0.39) • Both (HR 0.17) 👉 Huge mortality reductions – but major treatment gaps remain link.springer.com/article/10.118…

Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology: JACC Journals and American College of Cardiology 🥸 Inflammation and aging are interlinked: #inflammaging 😱 Great science statement here 👇👇👇

Officially a third year PhD student!! 🥳🥳 I’ve had the most wonderful 2 years working with the legendary Claire E. Hills Paul E. Squires and team University of Lincoln CardioRenal Group 😍 I am grateful everyday to do research I love with such wonderful people #phdlife #phdchat #womeninSTEM

Postponed celebrations with Paul E. Squires now in full swing 🥂🍾 #WomeninSTEM #AcademicTwitter #diabetes #diabetesresearch #GrantSuccess #Celebratethewins #kidneydisease #type2diabetes #lifeofapi

Huge congratulations to the brilliant Claire E. Hills Paul E. Squires you are so deserving of ALL the wins and it is such a testament to all of your hard work - enjoy that fizz 😍😍 #womeninstem #womeninscience #grantsuccess #diabetesresearch #phdlife #kidneyresearch

We authored this state-of-the-art review, now published in JACC, to provide an updated, comprehensive overview of post–myocardial infarction inflammatory mechanisms and to critically evaluate the emerging clinical evidence on anti-inflammatory therapies for secondary